Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moises Labrador-Horrillo

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2019
Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical TrialGabriel Gastaminza, Julian Azofra, Jorge M Nunez-Cordoba, et al.
Allergologia Et Immunopathologia|July 6, 2024
A real-life ImmunoCAT study: impact of molecular diagnosis through ImmunoCAP<sup>TM</sup> ISAC 112 on immunotherapy prescription in pollen-polysensitized patients in Catalonia, SpainTeresa Garriga-Baraut, Moises Labrador-Horrillo, Mercé Tena, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2019
Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical TrialGabriel Gastaminza, Julian Azofra, Jorge M Nunez-Cordoba, et al.
Allergologia Et Immunopathologia|July 6, 2024
A real-life ImmunoCAT study: impact of molecular diagnosis through ImmunoCAP<sup>TM</sup> ISAC 112 on immunotherapy prescription in pollen-polysensitized patients in Catalonia, SpainTeresa Garriga-Baraut, Moises Labrador-Horrillo, Mercé Tena, et al.
Pageof 3